Neuromodulation market Trends, Size, Competitive Analysis and Forecast 2019-2025
Neuromodulation market is expected to grow at a significant rate during the forecast period 2019-2025. Neuromodulation uses pharmaceutical agents, electrical signals, or other forms of energy for stimulating nerves by modulating abnormal neural pathway behavior caused by the disease. The neuromodulation treatment approach involves non-invasive techniques such as transcranial magnetic stimulation as well as implanted devices including spinal cord stimulation or a deep brain stimulation system. The global neuromodulation market is estimated to grow at a significant rate during the forecast period.
To Request a Sample of our Report on Neuromodulation market: https://www.omrglobal.com/request-sample/neuromodulation-market
The major factor that is contributing to the growth of the global
neuromodulation market includes the increasing prevalence of neurological
disorder. In addition, the rapid rise in the geriatric population pool further
boosts the growth of the global neuromodulation market, as this population pool
is more vulnerable to neurological disorders such as Alzheimer’s disease.
Further, increasing awareness regarding the safety and efficacy of
neurostimulator devices is also surging the growth of the global
neuromodulations market. However, factors such as stringent government
regulations, and a dearth of trained healthcare professionals serve as the
major barriers in the growth of the market across the globe.
A
full Report of Neuromodulation market is Available at: https://www.omrglobal.com/industry-reports/neuromodulation-market
Neuromodulation
Market Segmentation
·
Internal
Neuromodulation
·
Spinal
Cord Stimulation (SCS)
·
Deep
Brain Stimulation (DBS)
·
Sacral
Nerve Stimulation (SNS)
·
Vagus
Nerve Stimulation (VNS)
·
Gastric
Electrical Stimulation (GES)
·
External
Neuromodulation
·
Transcutaneous
Electrical Nerve Stimulation (TENS)
·
Transcranial
Magnetic Stimulation (TMS)
·
Respiratory
Electrical Stimulation (RES)
By
Application
·
Chronic
Pain
·
Parkinson’s
Disease
·
Obsessive
Compulsive Disorder (OCD)
·
Treatment-Resistant
Depression (TRD)
·
Urinary
and Fecal Disorders
·
Others
(Ischemia, Epilepsy)
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company
Profiles
·
Abbott Laboratories
Inc.
·
Aleva
Neurotherapeutics SA
·
Bioness
Inc.
·
Boston
Scientific Corp.
·
Cogentix
Medical, Inc.
·
Cyberonics
Inc.
·
Integer
Holdings Corp.
·
LABORIE
Medical Technologies Inc.
·
LivaNova,
PLC
·
Medtronic
PLC
·
Neuronetics
Inc.
·
NeuroPace
Inc.
·
NeuroRecovery
Technologies Inc.
·
Neurosigma
Inc.
·
Neuspera
Medical Inc.
·
Nevro
Corp.
·
PathMaker
Neurosystems Inc.
·
Soterix
Medical Inc.
·
Synapse
Biomedical Inc.
·
Tivic
Health Systems Inc.
·
Xavant
Technology
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/neuromodulation-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment